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Abstract 
Wastewater-based epidemiology (WBE) applies advanced analytical methods to quantify drug 25 
residues in wastewater with the aim to estimate illicit drug use at the population level. Transformation 
processes during transport in sewers (chemical and biological reactors) and storage of wastewater 
samples before analysis are expected to change concentrations of different drugs to varying degrees. 
Ignoring transformation for drugs with low to medium stability will lead to an unknown degree of 
systematic under- or overestimation of drug use, which should be avoided. This review aims to 30 
summarize the current knowledge related to the stability of commonly investigated drugs and, 
furthermore, suggest a more effective approach to future experiments. From over 100 WBE studies, 
around 50 mentioned the importance of stability and 24 included tests in wastewater. Most focused on 
in-sample stability (i.e., sample preparation, preservation and storage) and some extrapolated to in-
sewer stability (i.e., during transport in real sewers). While consistent results were reported for rather 35 
stable compounds (e.g., MDMA and methamphetamine), a varying range of stability under different or 
similar conditions was observed for other compounds (e.g., cocaine, amphetamine and morphine). 
Wastewater composition can vary considerably over time, and different conditions prevail in different 
sewer systems. In summary, this indicates that more systematic studies are needed to: i) cover the 
range of possible conditions in sewers and ii) compare results more objectively. To facilitate the latter, 40 
we propose a set of parameters that should be reported for in-sewer stability experiments (laboratory 
and full-scale). Finally, a best practice of sample collection, preservation, and preparation before 
analysis is suggested in order to minimize transformation during these steps. 
 
Keywords: Transformation, sewage epidemiology, sample preservation, psychoactive substances, 45 
biodegradation. 
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Abbreviations 
6-MAM  6-monoacetyl morphine 
AMP  Amphetamine 
BE  Benzoylecgonine 70 
COC  Cocaine 
COCA  Cocaethylene 
COD  Codeine 
EDDP  2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine 
EME  Ecgonine methyl ester  75 
KET  Ketamine 
LSD  Lysergic acid diethylamide 
MBDB  Methylbenzodioxolylbutanamine 
MDA  3,4-methylenedioxyamphetamine  
MDEA  3,4-methylenedioxy-N-ethylamphetamine  80 
MDMA  3,4-methylenedioxy-methamphetamine 
METH  Methamphetamine 
MOR  Morphine 
MTD  Methadone 
nor-BE  Nor-benzoylecgonine  85 
nor-COC Nor-cocaine 
SPE  Solid-phase extraction 
SPM  Suspended particulate matter 
THC  Δ9-tetrahydrocannabinol 
THC-COOH 11-nor-9-carboxy-THC  90 
THC-OH 11-hydroxy-THC 
TSS  Total suspended solids 
VSS  Volatile suspended solids 
WBE  Wastewater-based epidemiology 
95 
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1 Introduction 
Wastewater-based epidemiology (WBE) is a recently introduced monitoring tool in drug 
epidemiology. It provides objective information about the levels and patterns of drug use at the 
population level and as such is complementary to existing survey-based methods. It has also the 
potential to serve as an early warning system for the use of new psychoactive substances (NPS, e.g., 100 
Kinyua et al., 2015; Reid et al., 2014) and to investigate the effectiveness of intervention programs 
(e.g., Burgard et al., 2014; Castiglioni et al., 2014). The principle of WBE is predicated by the fact that 
substances are excreted as parent compounds and/or metabolites - subsequently referred to as 
biomarkers (of illicit drugs) - after consumption and transported through the sewer network to 
wastewater treatment plants (Figure 1).  105 
 
Figure 1. System boundaries used in wastewater-based epidemiology. 
 
The concentrations of biomarkers in the wastewater (ci) can be quantified with advanced analytical 
instruments, such as liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). 110 
Consumption estimates are calculated according to Eq. 1:  
           
         
          
     (1) 
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where Q = wastewater volume, ci = concentration of drug i, m i = molar mass ratio (parent to 
metabolite), P = population for normalization, ei = drug-specific pharmacokinetic excretion rate 
(average or distribution of urinary excretion, e.g., van Nuijs et al., 2011a; Zuccato et al., 2005) and pi 115 
= purity of drug. In 2005, WBE was applied for the first time, back-calculating the cocaine use of 
communities in Italy (Zuccato et al., 2005). Since then, studies have compared temporal and spatial 
drug use trends by consumption differences between rural and metropolitan areas (e.g., Irvine et al., 
2011; van Nuijs et al., 2009a; van Nuijs et al., 2011b), among different countries (e.g., Ort et al., 2014; 
Thomas et al., 2012) and during special events (festivals, holidays (e.g., Lai et al., 2013)) to name 120 
some of several applications.  
Most illicit drugs may or may not have licit medical purposes, but they are produced, trafficked and/or 
consumed illegally on a large scale (United Nations Office of Drug and Crime, 2014). In this review, 
we focus on the most frequently used illicit drugs and their metabolites: cocaine, amphetamines and 
amphetamine-type substances, opiates, cannabinoids and selected other illicit substances, such as 125 
ketamine (KET) and lysergic acid diethylamide (LSD). 
One of the main challenges in WBE is to reduce the uncertainty of each variable in the back-
calculation equation (Eq. 1). High uncertainty is related to the excretion rates based on 
pharmacokinetic literature (Castiglioni et al., 2013) and the chemical analysis of the biomarkers in the 
complex wastewater matrix. Numerous efforts have focused on improving the accuracy (trueness and 130 
precision) of different analytical methods, and inter-laboratory studies were conducted in order to 
evaluate and harmonize the different analytical procedures being used (Castiglioni et al., 2013; 
Thomas et al., 2012). Uncertainties associated with the population estimates have recently been 
conceptually reduced (Lai et al., 2015; O’Brien et al., 2014), as well as the uncertainty related to 
wastewater sampling (Ort et al., 2010). Furthermore, sample collection, storage and preparation 135 
methods have been evaluated, deducing critical, substance-specific parameters: i) solvent and 
temperature used during the evaporation of solid-phase extraction (SPE) extracts, and ii) biomarker 
stability in the wastewater matrix and silanisation of glassware (Baker and Kasprzyk-Hordern 2011a). 
To further minimize uncertainty of WBE, a better understanding of in-sewer and in-sample stability of 
biomarkers is needed (Fig. 1).   140 
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Castiglioni et al. (2013) estimated that the uncertainty related to the stability of the biomarkers during 
in-sewer transport is less than 10%. However, they also concluded that more research is needed. Other 
studies urge the consideration of the stability of the illicit drug biomarkers in the back-calculation 
method (van Nuijs et al., 2009b; Östman et al., 2014).  
While in-sample stability has been studied to some degree for most of the biomarkers (e.g., Baker and 145 
Kasprzyk-Hordern, 2011a; Chen et al., 2013; Östman et al., 2014), their in-sewer stability under the 
influence of varying environmental conditions is not well understood. The sewer is considered a 
biological and chemical reactor, influenced by physical processes (Hvitved-Jacobsen et al., 2013). 
Residence times of 30min to 12h (rarely up to 24h) in most catchments and potential environmental 
processes facilitate formation of transformation products (Heuett et al., 2015a). Consequently, the 150 
omission of biomarker-specific in-sewer transformation may add an unknown level of uncertainty. 
Yet, only few studies have investigated in-sewer stability of selected biomarkers under environmental 
conditions (Senta et al., 2014; Thai et al., 2014; van Nuijs et al., 2012) and accounted for stability in 
the back-calculation of drug use (Baker et al., 2014; Östman et al., 2014). 
In this review, we summarize and critically evaluate the available scientific literature focusing on the 155 
stability of the most frequently used illicit drugs during i) in-sewer transport and ii) in-sample storage. 
Using this information, more insight is obtained regarding the uncertainty of WBE associated with 
stability and, additionally, suggestions for best practices in future stability studies are provided. 
1.1 Environmental processes in sewer networks 
In general, two major categories of processes determine the overall fate of illicit drug biomarkers in 160 
the sewer network. First, mass transfer processes that leave the structure of the chemicals unchanged, 
e.g., transport, mixing and transfer among different phases and/or compartments (sorption, 
sedimentation, and uptake by organisms). The second category includes processes that alter the 
structure of the compounds, e.g., chemical and/or biological transformation reactions (Schwarzenbach 
et al., 2003b). For the remainder of the manuscript, the term transformation will be used to refer to any 165 
of these three processes, although physical processes are rather transfer, not transformation, processes. 
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Wastewater contains a large number of soluble, colloidal, and suspended components (e.g., nutrients, 
metals, micropollutants and pathogenic and nonpathogenic microorganisms). Its content varies in time 
and space, which favors or inhibits specific environmental processes. In addition, sewer designs and 
operation modes influence the prevailing conditions, e.g., oxygen concentrations (redox potential), pH, 170 
temperature, flow velocities and sediments (Figure 2). The dominating processes that may influence 
biomarker concentrations in the sewer are most likely residence time, abiotic and biotic 
transformations (e.g., hydrolysis, deconjugation, biodegradation), as well as sorption to SPM. Further, 
the presence of biofilms on the sewer walls should be accounted for (Hvitved-Jacobsen et al., 2013).  
 175 
Figure 2. Cross-sections of gravity driven and pressurized sewers. 
 
1.2 Stability of illicit drug biomarkers during wastewater treatment processes 
and in the environment 
It is noteworthy that compounds may also be transformed through numerous processes, e.g., 180 
chlorination or ozonation, during wastewater treatment or photodegradation in the environment. 
Effects of these processes and resulting transformation products were beyond the scope of this review. 
To fully assess their fate, transport and toxicological impact on the natural environment, 
comprehensive monitoring and additional investigations are needed (Bijlsma et al., 2013; Heuett et al., 
2015a). Several reviews are available for these pertinent topics (Bijlsma et al., 2013; Boix et al., 2014; 185 
Postigo et al., 2011a, 2011b; Rodayan et al., 2014; Heuett et al., 2015a). 
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2 Summary of reviewed studies  
More than 50 WBE studies mentioned the importance of stability, from which 24 actually investigated 
in-sewer or in-sample stability to some extent. Overall, a clear distinction between in-sewer and in-
sample stability is lacking in the current literature.  190 
2.1 General setup 
In-sewer stability experiments should account for all relevant processes occurring in sewer 
compartments: i) the bulk liquid (wastewater with suspended particulate matter (SPM)), ii) the biofilm 
growing on the sewer walls, iii) the sediments, and iv) the sewer atmosphere in gravity sewers. Most 
studies only investigated the stability in the bulk liquid. No experiments to date have investigated the 195 
effect of sewer sediments or the sewer atmosphere on biomarker transformation. Focusing on illicit 
drugs, only one pilot-scale sewer reactor study included the sewer wall biofilm (Thai et al., 2014). 
Considering the physico-chemical properties of most biomarkers (Table S1) and their hydrophilic 
character, precipitation and evaporation seem negligible (Ternes and Joss, 2006). 
In this review, we consider all laboratory studies using unfiltered wastewater at a typical pH around 7-200 
8, at temperatures above 10°C as in-sewer studies. Nonetheless, the experimental setups of these 
studies differed in complexity with different degrees of approximation. Several research groups 
conducted stability studies as part of a validation method, and only a few publications showcased an 
exclusive focus on analyte stability in wastewater. Consequently, the main study conditions are 
summarized in Table 1. Usually, the concentration of biomarkers in spiked, unfiltered wastewater was 205 
monitored in glass or plastic containers, in the dark, under constant pH and temperature, over periods 
of 12-72h. Six publications considered the fraction of biomarker that bound to SPM or sludge (in 
wastewater treatment plants).
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Table 1. Overview of experimental conditions 
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Baker and Kasprzyk-
Hordern, 2011a 
x     unfiltered WW 
target 
1 µg/L 0, 12, 24, 72 h 
amber silanized 
glass bottles 
pH 7.4 19 °C 
NA   x   
unfiltered and filtered 
WW 
1 µg/L 0, 12, 24, 72 h pH 7.4 and 1.8 
2°C and 
19°C 
  xa   
filtered WW (filter type 
not reported) 
1 µg/L 0, 2, 4,6 weeks pH 2 -20°C 
Baker and Kasprzyk-
Hordern, 2011b 
    x unfiltered WW target none not relevant 
amber silanised 
bottles 
NA NA NA 
Bisceglia and Lippa, 
2014 
x     
WW (coarsely filtered 
11µm Whatman Nb1) 
target 
3-600x the 
background 
concentrations 
> 10 x over 24 h 
1-L glass 
Erlenmeyer flask 
pH 7.3 
9°C, 23°C, 
31°C 
NA 
Boix et al., 2014   x   WW, surface water suspect 1000 µg/L 
0, 1, 3, 7, 10, 17 
days 
NA NA 
room 
temperature 
NA 
Burgard et al., 2013   x   unfiltered WW target 1 µg/L 8 x over 72 h glass container NA max. 20°C NA 
Castiglioni et al., 2011a   x   unfiltered WW target 1-5 µg/L 
0, 1, 3 days; 3 
freeze-thaw cycles 
glass bottles NA 
4°C, -20°C 
freeze-and-
thaw 
NA 
Castiglioni et al., 2006   x   unfiltered WW target 0.5-5 µg/L 0, 3 days glass bottles NA 4°C NA 
Castiglioni et al., 2015 
  x   unfiltered WW 
target 
0.1 µg/L 0, 3, 6, 24, 48 h  glass bottles NA 
4°C; room 
temperature 
NA 
x     unfiltered WW 0.1 µg/L 0, 3, 6, 24, 48 h  glass bottles NA 
room 
temperature 
NA 
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Chen et al., 2013 
x     unfiltered WW 
target 
> 0.1 µg/L 0, 1, 2, 3, 7, 14 days NA NA 20°C NA 
  x   
unfiltered WW, filtered 
WW, unfiltered WW 
+Na2S2O5 
> 0.1 µg/L 0, 1, 2, 3, 7, 14 days NA 
pH of WW (~7)  
and at pH 2 
20°C, 4°C 
and -20°C 
NA 
Chiaia et al., 2008   x   unfiltered WW target 0.2 µg/L 
1, 2, 3, 4, 7, 14, 21 
days 
HDPE bottles 
pH of WW (~7) 
and at pH 2 
room 
temperature, 
4°C, -20°C 
NA 
Gheorghe et al., 2008   x   surface water target 0.1-0.4 µg/L 0, 1, 3, 5 days glass bottles pH 6 and 2 
−20°C, 4°C 
and 20°C 
NA 
 González-Mariño et al., 
2010 
  x   
filtered WW and filtered 
WW +NaN3 
target 100 µg/L 
0, 1, 3, 5, 7, 14, 21, 
84 days 
amber glass 
bottles 
NA 
4°C and -
20°C 
NA 
Heuett et al., 2015b   x   unfiltered WW target 0.25 µg/L 
0, 3, 7, 17, 27, and 
123 days 
glass bottles NA -20°C NA 
Jelic et al., 2014 x     
unfiltered WW 
+sewerwall biofilm 
target no spike 0, 21 h NA (real sewer) pH 7.2-7.6 22°C anaerobic 
Langford et al., 2011     x sludge target no spike not relevant 
silanized glass 
flask 
NA NA NA 
Mardal and Meyer, 2014 xb     
unfiltered WW, 
unfiltered WW +rat urine 
and feces 
suspect 100 µg/L 
0, 1, 2, 3, 4, 5, 6, 7 
days 
amber glass 
bottles 
NA 22°C aerobic 
Metcalfe et al., 2010     x unfiltered WW suspect none not relevant NA pH 3 NA NA 
Östman et al., 2014   x   
filtered WW; purified 
water 
target 0.9 µg/L 0, 24 h 
polyethylene 
bottles (HDPE) 
NA 
room 
temperature; 
4°C 
NA 
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Plósz et al., 2013 
x     
unfiltered WW + 
activated sludge 
target 
no spike 
0, 15, 30, 60, 90, 
120 min, 4, 6, 8, 10, 
16, 18 and 24 h 
glass reaction 
vessel 
pH 7.4 21°C 
aerobic 
and 
anaerobic 
    x 
preclarified WW 
+mercury chloride 
no spike 
0, 10, 20, 30, 45, 60 
min 
glass reaction 
vessel 
pH 7.4 NA NA 
Rosa Boleda et al., 2011   x   drinking water target none 0, 3, 5, 8 days 
sterilized 
polypropylene 
bottles with 
sodium thiosulfate 
NA 
4°C and 
room 
temperature 
NA 
Senta et al., 2014 
x     unfiltered WW 
target 
0.2 µg/L, 
cannabinioids 1 
ug/L 
0, 4, 6, 24, 48, 72 h glass bottles pH 7.5 10° and 20° NA 
    x unfiltered WW 4 μg/L 0, 4, 6, 24, 48, 72 h glass bottles pH 7.5 10° and 20° NA 
  x   unfiltered WW 0.25 µg/L 0, 24 h 
HD polypropylene 
bottles 
pH 7.5 and 2 4°C NA 
Senta et al., 2013     x 
unfiltered raw WW, 
secundary effluent WW, 
activated sludge 
target none not relevant NA pH≈7.5 NA NA 
Subedi and Kannan, 
2014 
    x 
unfiltered raw WW, 
primary effluent WW, 
secundary effluent WW, 
activated sludge, sludge 
target none not relevant amber glass jars NA NA NA 
Thai et al., 2014 x     
unfiltered WW in sewer 
pilot reactor with 
sewerwall biofilm 
target 
deuterium labelled 
substances 10 µg/L;  
0, 0.25, 0.5, 1, 2 ,3, 
6, 9 and 12 h 
PerspexTM pH 7.5 20°C 
gravity 
sewer 
(aerobic) 
and rising 
main 
sewer 
(anaerobic) 
van Nuijs et al., 2012 x     unfiltered WW target 0.12 - 1.6 ug/L  
0, 1, 2, 3, 4, 5, 6, 7, 
8, 9, 10, 11, 12, 26 h 
silanized glass 
flask 
pH 7.5 20°C NA 
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Wick et al., 2011 (x)c     
unfiltered WW+activated 
sludge 
suspect 2 µg/L 8x over 3 days 
amber glass 
bottles 
regulated at pH 
7 (±0.2) 
NA aerobic 
a longterm stability study; b incubation of WW with rat urine and feces to mimick human excreation;  c Matrix was enriched with activated sludge to mimick the wastewater 
treatment   
 210 
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For most biomarkers, we found a range of transformation values, most likely as a result of different 
environmental conditions that were tested. Therefore, we propose to rate in-sample stability and in-
sewer stability separately for each substance based on the available literature and our judgment: low 
stability (60-100% transformation), medium stability (20-60% transformation), high stability (0-20% 215 
transformation), or variable stability over 24h. The knowledge for the main groups of compounds is 
described in the subsequent sections. For other compounds and further information, see Table 2.
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Table 2. Literature summary of stability of illicit drug biomarkers from in-sewer and in-wastewater samples. 
In-sewer stability WW = wastewater    *Substances used for consumption back-calculation 
In-sample stability 
The stability of each substance during in-sewer transport and in-sample is rated as: stability is low (60-100% transformation), 
medium (20-60% transformation), high (0-20% transformation) or variable (if not otherwise indicated over 24h). 
G
ro
u
p
 
Parent Metabolite 
#
 s
ta
b
il
it
y
 
st
u
d
ie
s 
Stability References 
C
o
ca
in
e 
a
n
d
 m
et
a
b
o
li
te
s 
Cocaine (COC)   
10 
Low: 60% transformation over 12 h @ 20°C in gravity sewer laboratory 
reactor --> 100% transformation expected over 24 h. In raising main 
laboratory reactor 45% transformation occured over 12 h; with activated 
sludge 100% transformation over 24 h at 21°C and pH 7.4 
Baker and Kasprzyk-Hordern, 2011a; Bisceglia and 
Lippa, 2014; Chen et al., 2013; Plósz et al., 2013; 
Senta et al., 2013, 2014; Subedi and Kannan, 2014; 
Thai et al., 2014;  van Nuijs et al., 2012; Wick et al., 
2011 
12 
Low: at neutral pH: at 4°C, 9°C, 19°C, 20°C, 23°C & 31°C over 1-3 d; 
filtered/unfiltered WW at 2°C & 19°C over 3 d (slightly higher for 
unfiltered WW at 20°C over 3 d but lower afterwards); after two freeze-
and-thaw cycles within 3 d. High: neutral pH: at -20°C over 3 weeks; at 
2°C over 3 d; low pH: at 2°C & 19°C - 20°C over 3 d; at -20°C over 3 
weeks; at 37°C over 3.5 h; in Milli-Q water at 4°C & 25°C for 24 h; with 
Na2S2O2 at 20°C for 2 weeks; absorbed on SPE cartridges (HLB) over 12 
weeks 
Baker and Kasprzyk-Hordern, 2011a, 2011b; 
Castiglioni et al., 2006, 2011a; Chen et al., 2013; 
Chiaia et al., 2008; Gheorghe et al., 2008; González-
Mariño et al., 2010; Heuett et al., 2015b; Metcalfe 
etal., 2010; Östman et al., 2014; Senta et al., 2014 
  
benzoylecgonine* 
(BE) 
10 
Medium: 14% transformation over 12 h @ 20°C in gravity sewer 
laboratory reactor --> ca. 28% transformation expected over 24 h. In raising 
main sewer 8% transformation occured over 12 h; with activated sludge 
80% transformation over 24 h at 21°C and pH 7.4 
Baker and Kasprzyk-Hordern, 2011a; Bisceglia and 
Lippa, 2014; Chen et al., 2013; Plósz et al., 2013; 
Senta et al., 2013, 2014; Subedi and Kannan, 2014; 
Thai et al., 2014;  van Nuijs et al., 2012; Wick et al., 
2011 
12 
High: at low pH: at 2°C & 19°C - 20°C over 3 d; at -20°C over 3 weeks; at 
37°C over 3.5 h; at neutral pH: at -20°C over 3 weeks; at 2°C, 4°C, 9°C, 
19°C, 20°C, 23°C & 31°C over 1-3 d, 7 d; filtered / unfiltered WW at 2°C 
& 19°C over 3 d (higher for filtered WW at 20°C over 14 d); in Milli-Q 
water at 4°C & 25°C for 24 h; after two freeze-and-thaw cycles within 3 d; 
with Na2S2O2 at 20°C for 2 weeks; absorbed on SPE cartridges (HLB) over 
12 weeks 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006, 2011a; Chen et al., 2013; Chiaia et al., 2008; 
Gheorghe et al., 2008; González-Mariño et al., 2010; 
Heuett et al., 2015b; Metcalfe etal., 2010; Östman et 
al., 2014; Senta et al., 2014 
  
ecgonine methyl 
ester (EME)  
3 
Medium: 20-40% loss in unfiltered WW (pH 7.5, 20-23°C) and and 
surface water (pH 6, 20°C); Low: with activated sludge >80% 
transformation over 24 h at 21°C, pH 7.4 
Bisceglia and Lippa, 2014; Plósz et al., 2013; van 
Nuijs et al., 2012 
3 
Low: at neutral pH at 4°C, 9°C, 20°C, 23°C & 31°C over 1-3 d; after two 
freeze-and-thaw cycles within 3 d 
Castiglioni et al., 2011a; Gheorghe et al., 2008; 
González-Mariño et al., 2010 
  nor- 1 <5% change in unfiltered WW (pH 7.4, 19°C) Baker and Kasprzyk-Hordern, 2011a 
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benzoylecgonine 
(nor-BE)  
4 
High: at low pH: at 2°C & 19°C over 3 d; at -20°C over 3 weeks; at neutral 
pH: at -20°C over 3 weeks;  at 2°C, 4°C & 19°C over 1 - 3 d; filtered / 
unfiltered WW at 2°C & 19°C over 3 d (similar); after two freeze-and-thaw 
cycles within 3 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006, 2011a; Chiaia et al., 2008; González-Mariño 
et al., 2012 
  
nor-cocaine (nor-
COC) 
1 <30% change in unfiltered WW (pH 7.4, 19°C) Baker and Kasprzyk-Hordern, 2011a 
5 
High: at 2°C, 4°C & 19°C over 1-3 d; in filtered > unfiltered WW at 2°C & 
19°C over 3 d; at low pH: at 2°C & 19°C over 3 d; -20°C over 3 weeks; at 
neutral pH: at -20°C over 3 weeks; Low: after two freeze-and-thaw cycles 
within 3 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006, 2011a; Chiaia et al., 2008; González-Mariño 
et al., 2012; Subedi and Kannan 2012 
  
cocaethylene 
(COCA) 
2 Medium: 20-50% change in unfiltered WW (pH 7.4, 19-23°C) 
Baker and Kasprzyk-Hordern, 2011a; Bisceglia and 
Lippa, 2014 
5 
Variable: High: at low pH at 2°C & 19°C over 3 d; at neutral pH at 2°C, 
9°C  and 19°C over 1-3 d; in filtered > unfiltered WW at 2 & 19°C over 3 
d; Low: at neutral pH at 23°C & 31°C over 1-3 d; after two freeze-and-
thaw cycles within 3 d.  
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006, 2011a; Chiaia et al., 2008; González-Mariño 
et al., 2012; Heuett et al., 2015; Subedi and Kannan 
2012 
A
m
p
h
et
a
m
in
e-
ty
p
e 
su
b
st
a
n
ce
s 
amphetamine* (AMP)   
3 Variable: -40% in unfiltered WW (pH 7.4, 19°C), <20% loss (pH 7, 20°C) 
Baker and Kasprzyk-Hordern, 2011a; Chen et al., 
2013; Senta et al., 2014 
9 
 Variable: most studies found <10% transformation at 4°C and  20°C up to 
24 h;  one study measured increase of 26-73% at 2°C and room temperature 
over 24h (may be formed from other substances); over 3 d at 13°C AMP 
decreased (38% transformation); High stability at -20°C in unfiltered WW 
for up to 123 d; stable over 72 h at 37°C in urine 
Baker and Kasprzyk-Hordern, 2011a; Burgard et al., 
2013; Castiglioni et al., 2006; Chen et al., 2013; 
Chiaia et al., 2008; González-Mariño et al., 2010; 
Heuett et al., 2015b; Östman et al., 2014; Senta et al., 
2014 
methamphetamine* (METH)   
4 
High: 5% transformation over 12 h @ 20°C in gravity sewer laboratory 
reactor --> ca. 10% transformation expected over 24 h. In raising main 
sewer 0% transformation occured over 12 h. 
Baker and Kasprzyk-Hordern, 2011a; Chen et al., 
2013; Senta et al., 2014; Thai et al., 2014 
9 
High: transformation <10% up to 24 h at  4°C and  20°C; <10% 
degradation at -20°C over 123 d 
Baker and Kasprzyk-Hordern, 2011a; Burgard et al., 
2013; Castiglioni et al., 2006; Chen et al., 2013; 
Chiaia et al., 2008; González-Mariño et al., 2010; 
Heuett et al., 2015b; Östman et al., 2014; Senta et al., 
2014 
3,4-methylene-dioxymeth-
amphetamine* (MDMA) 
  
4 
High: <10% transformation over 12 h @ 20°C in gravity sewer laboratory 
reactor. In raising main sewer <10% transformation occured over 12 h. 
Baker and Kasprzyk-Hordern, 2011a; Chen et al., 
2013; Senta et al., 2014; Thai et al., 2014 
9 
High: transformation <10%  up to 24 h at 4°C and  20°C; <20% 
degradation at -20°C over 123 d 
Baker and Kasprzyk-Hordern, 2011a; Burgard et al., 
2013; Castiglioni et al., 2006; Chen et al., 2013; 
Chiaia et al., 2008; González-Mariño et al., 2010; 
Heuett et al., 2015b; Östman et al., 2014; Senta et al., 
2014 
  
3,4-methylene-
dioxyamphetamine 
(MDA) 
2 High: <10% transformation in unfiltered WW 19/20°C at pH 7.4 
Baker and Kasprzyk-Hordern, 2011a, Chen et al., 
2013 
6 
High: transformation <10% up to 72 h at 4°C and  20°C; <30% 
transformation at -20°C over 123 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Chen et al., 2013; Chiaia et al., 2008; 
González-Mariño et al., 2010; Heuett et al., 2015b; 
Östman et al., 2014 
Page 16 of 38 
 
  
3,4-methylene-
dioxy-Nethyl-
amphetamine 
(MDEA) 
1 <10% transformation in unfiltered WW 19°C at pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
6 
High: transformation <10% up to 24 h at  4°C and  20°C; <20% 
degradation at -20°C over 123 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Chiaia et al., 2008; González-Mariño et al., 
2010; Heuett et al., 2015b; Östman et al., 2014 
methylbenzodioxolyl-
butanamine (MBDB) 
  
1 <20% transformation in unfiltered WW 19°C at pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
2 High: transformation <10% up to 24 h at  4°C and  20°C 
Baker and Kasprzyk-Hordern, 2011a; Östman et al., 
2014 
methylenedioxypyrovalerone* 
(MDPV) 
  
1 in unfiltered WW no transformation at 22°C Mardal et al. 2014 
1 
transformation <10% after 24 h at 22°C in wastewater; in urine stable over 
14 d at room temperature, 4°C and -20°C 
Mardal et al. 2014 
methylphenidate* (ritalin)   
0 NA NA 
1 
36% transformation at 4°C and 88% transformation at room temperature 
over 24 h in wastewater; in milliQ <10% transformation 
Östman et al., 2014 
  ritalinic acid* 
0 NA NA 
1 <10% transformation after 72 h in wastewater at 20°C Burgard et al., 2013 
mephedrone*   
0 NA NA 
1 
in wastewater <10% transformation during 24 h at room temperature and at 
4 °C 
Östman et al., 2014 
O
p
ia
te
s 
heroin   
1 in unfiltered WW >90% transformation at 19°C and pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
3 
Low: transformed 66% after 12 h at 2°C and 79% at 19°C; 50% 
degradation at -20°C over 7 d and >90% over 123 d 
Baker and Kasprzyk-Hordern, 2011a; González-
Mariño et al., 2010; Heuett et al., 2015b  
  
6-mono-acetyl-
morphine* (6-
MAM) 
3 
Low: 88% transformation over 12 h @ 20°C in gravity sewer laboratory 
reactor --> ca. 100% transformation expected over 24 h. In raising main 
sewer 87% transformation occured over 12 h. 
Baker and Kasprzyk-Hordern, 2011a; Senta et al., 
2014; Thai et al., 2014 
5 
Low: degraded quickly in WW (6% transformation at 20°C over 12 h); but 
relatively stable in milliQ; High: <20% degradation at -20°C over 3, 7, 17, 
27 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Heuett et al., 2015b; Östman et al., 2014; 
Senta et al., 2014 
methadone* (MTD)   
3 
Variable: in unfiltered WW <10% loss at 19/20°C and pH 7.4; +10% at 
20°C in unfiltered WW pH 7.5; may be prone to sorption 
Baker and Kasprzyk-Hordern, 2011a; Senta et al., 
2014; van Nuijs et al., 2012 
8 
Variable: <20% difference at room temperature and 4°C; may be prone to 
sorption;  >40% degradation at -20°C over 123 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Rosa Boleda et al., 2011; Chiaia et al., 2008; 
González-Mariño et al., 2010; Heuett et al., 2015b; 
Östman et al., 2014; Senta et al., 2014 
  
2-ethylidene-1,5-
dimethyl-3,3-
1 
in unfiltered WW ca.20% loss at 19°C and pH 7.4; may be prone to 
sorption 
Baker and Kasprzyk-Hordern, 2011a 
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diphenyl-
pyrrolidine* 
(EDDP) 
5 
Variable: less than 15% difference after 24 h; may be prone to sorption; ca. 
40% degradation at -20°C over 3, 7 and 123 d 
Baker and Kasprzyk-Hordern, 2011a; Rosa Boleda et 
al., 2011; Castiglioni et al., 2006; Heuett et al., 2015b; 
Östman et al., 2014 
morphine* (MOR)   
2 
Variable: in unfiltered WW up to 50% loss (19°C, pH 7.4); up to 20% 
increase (20°C, pH 7.5) (transformation product of other substances) 
Baker and Kasprzyk-Hordern, 2011a; Senta et al., 
2014 
5 
Variable: difficult to judge because of the generation of morphine from 
other drugs; generally relativ high stablity at 4°C in unfiltered WW over 24 
h; <20% degradation at -20°C over 3, 7, 17, 27 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Heuett et al., 2015b; Östman et al., 2014; 
Senta et al., 2014 
  
morphine-3β-D-
glucuronide 
1 complete transformation in unfiltered WW pH 7.5 20°C Senta et al., 2014 
2 
Low: at pH 7.5 over 24 h at 20°C >80% transformation in WW; 96% 
transformation in WW at 4°C over 3 d; high: in WW at pH 2 over 78 h at 
20°C 
Castiglioni et al., 2006; Senta et al., 2014 
oxycodone*   
1 <10%  transformation in unfiltered WW at 19°C and pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
4 
High: stable (<20% transformation) at 19°C and pH 7.4; <10% degradation 
at -20°C over 3, 7, 17, 27, 123 d 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2006; Heuett et al., 2015b; Östman et al., 2014 
fentanyl*   
1 
<20% transformation in unfiltered WW at 19°C and pH 7.4; may be prone 
to sorption 
Baker and Kasprzyk-Hordern, 2011a 
3 
Variable/medium: <10% degradation in filtered WW at room temperature; 
<20% loss in unfiltered WW 19°C and pH 7.4 but 62% loss after 72h under 
same conditions; may be prone to sorption high: in milliQ 
Baker and Kasprzyk-Hordern, 2011a; Rosa Boleda et 
al., 2011; Östman et al., 2014 
buprenorphine*   
1  <10% transformation in unfiltered WW at 19°C and pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
1 
Variable: ca.30% formation in filtered WW at room temperature; <10% 
degradation in unfiltered WW at 4°C and 19°C and pH 7.4; high: in milliQ 
<10% transformation 
Baker and Kasprzyk-Hordern, 2011a; Östman et al., 
2014 
codeine* (COD)   
1 High: <20% transformation/formed in unfiltered WW at 19°C and pH 7.4 Baker and Kasprzyk-Hordern, 2011a 
4 
Variable: High: In filtered/unfiltered WW <20% transformation over 24 h 
at 4°C, 19°C and room temperature; may be formed from other substances; 
<10% degradation at -20°C over 3, 7, 17, 27, 123 d; Low: 80% transformed 
in diluted activated sludge pH 7 
Baker and Kasprzyk-Hordern, 2011a; Heuett et al., 
2015b; Östman et al., 2014; Wick et al., 2011 
C
a
n
n
a
b
in
o
id
s 
tetrahydro-cannabinol (THC)   
1 
 <20% transformation in unfiltered WW pH 7.5 20°C; may be lost due to 
sorption 
Senta et al., 2014 
1 
NA - almost no THC is excreted in human urine (Karch and Jenkins, 2006; 
Postigo et al., 2011; Lai et al., 2011); in spiked unfiltered WW stored at -
20°C 50% degradation over 7 days and >90% after 123 d 
Heuett et al., 2015b 
  THC-COOH* 1 
<20% transformation in unfiltered WW pH 7.5 20°C; may be lost due to 
sorption 
Senta et al., 2014 
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4 
Variable: may be lost due to sorption; High in WW at 4°C and 20°C over 
72 h; high on SPE cartridges over three weeks at -20°C; high at -20°C over 
3, 7, 17, 27, 123 d; Low at pH 2 over 24 h 
Boix et al., 2014; Castiglioni et al., 2006; González-
Mariño et al., 2010; Heuett et al., 2015b; Senta et al., 
2014 
  THC-OH 
1  <20% transformation in unfiltered WW pH 7.5 20°C Senta et al., 2014 
1 <20% transformation at pH 7.4, pH 2, 10°C and 20°C in unfiltered WW Senta et al., 2014 
O
th
er
 s
u
b
st
a
n
ce
s 
ketamine* (KET)   
2 High: <10% transformation in unfiltered WW pH 7.5, 20°C 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2015 
3 
High: at 4°C and room temperature at WW pH and acidified to pH 4 and in 
milliQ water at 4°C and room temperature 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2015; Östman et al., 2014 
  
norketamine 
(norKET) 
2 High: <10% transformation in unfiltered WW pH 7.5, 20°C 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2015 
3 
High: at 4°C and room temperature at WW pH and acidified to pH 4 and in 
milliQ water at 4°C and room temperature 
Baker and Kasprzyk-Hordern, 2011a; Castiglioni et 
al., 2015; Östman et al., 2014 
lysergic acid diethylamide* 
(LSD) 
  
1 <10% transformation in unfiltered WW pH 7.5, 20°C Baker and Kasprzyk-Hordern, 2011a 
4 
High: in WW pH and acidified to pH 2 at room temperature and at 4°C; 
Medium: in WW at room temperature up to 24% transformation; in milliQ 
water at 4°C and room temperature (40% transformation); over 3, 7, 17, 27, 
123 d at -20°C >20 and <50% degradation 
Baker and Kasprzyk-Hordern, 2011a; Chiaia et al., 
2008; Heuett et al., 2015b; Östman et al., 2014 
  
2-oxo-3-hydroxy-
LSD 
1  <20% transformation in unfiltered WW pH 7.5, 20°C Baker and Kasprzyk-Hordern, 2011a 
3 
High: at WW pH and acidified to pH 2 at room temperature and at 4°C; in 
milliQ water at 4°C and room temperature 
Baker and Kasprzyk-Hordern, 2011a; Chiaia et al., 
2008; Östman et al., 2014 
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2.2 Cocaine and metabolites 
In-sample stability of cocaine (COC) and its metabolites has been widely studied over a range of 220 
different conditions. These studies focused mostly on in-sample stability of COC and its main 
metabolite, benzoylecgonine (BE), which is used for back-calculation. Stability of COC was generally 
low under all tested conditions (Table 2). Hydrolysis of COC seems pH-dependent (Warner and 
Norman, 2000), and acidification of the sample can preserve COC concentrations at low and high 
temperatures over at least three days (Table 2). Transformation of COC can also be prevented using 225 
preservatives (e.g., sodium metabisulfite (Na2S2O5), sodium azide (NaN3)), and COC concentration 
changes seemed negligible after extraction onto SPE cartridges (HLB) (Chen et al., 2013; González-
Mariño et al., 2010).  
The wastewater matrix seems to have an influence on the extent of transformation (Castiglioni et al., 
2006, 2011a; Gheorghe et al., 2008). COC concentrations remained slightly higher over three days in 230 
unfiltered samples compared to filtered wastewater (20°C, pH 7) (Chen et al., 2013). At -20°C and pH 
7, COC concentrations in unfiltered wastewater only slightly decreased over three weeks (Chiaia et al., 
2008), and another study reported that COC can be stable over 24h in Milli-Q water at 4°C and 25°C 
(Östman et al., 2014). Furthermore, it is important to note that sorption to SPM of COC and its 
metabolites seems to be negligible (Baker and Kasprzyk-Hordern, 2011b), but COC concentrations in 235 
wastewater samples decreased during freeze-and-thaw cycles (Castiglioni et al., 2011).  
In-sewer stability of COC was relatively low over 12h at pH 7.1-7.5 and 20°C in a study considering 
aerobic and anaerobic sewer biofilms, in which transformation of COC appeared to be stronger under 
aerobic conditions, compared to anaerobic in-sewer conditions (Thai et al., 2014). 
Unlike COC, its main metabolite BE showed high in-sample stability under various conditions (Table 240 
2). In-sewer stability of BE with aerobic and anaerobic biofilms has been shown to be high at 20°C 
over 12h (Thai et al., 2014), whereas one study revealed a decrease of BE under aerobic and anaerobic 
conditions with activated sludge biomass at 21°C over 24h (Plósz et al., 2013). Information on other 
COC metabolites is listed in Table 2. 
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2.3 Amphetamine and amphetamine-type substances 245 
This group encompasses compounds with chemical structures similar to that of amphetamine (AMP). 
It includes methamphetamine (METH), 3,4-methylenedioxymethamphetamine (MDMA) and its 
metabolite 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxy-N-ethylamphetamine 
(MDEA), methylbenzodioxolylbutanamine (MBDB), as well as, the novel synthetic cathinones, 
cathinones HCl, methylenedioxypyrovalerone (MDPV), mephedrone, methylphenidate (ritalin) and its 250 
metabolite, ritalinic acid.  
In-sample stability of AMP in unfiltered wastewater has been consistently shown to be high at pH 7 at 
4°C and 20°C for 24h in most studies (Table 2). However, Baker et al. 2011a reported an increase 
(26%) of AMP concentrations at 2°C and pH 7 and a 73% increase in AMP at room temperature over 
24h. AMP is also a metabolite of METH, and the pharmaceuticals, selegiline and dextroamphetamine 255 
(Kraemer and Maurer, 2002; Heuett et al., 2015a). However, in-sample stability of METH is high in 
unfiltered wastewater at pH 7 at 4°C and room temperature (Table 2) and substantial in-sewer 
transformation of METH to AMP is thus unlikely. AMP and METH were reported as highly stable 
under all tested conditions, particularly after addition of NaN3 to the samples over three weeks, instant 
freezing (-20°C) over 123 days, and after acidification over three weeks (Table 2).  260 
MDMA, MDA and MDEA showed high in-sample stability in unfiltered wastewater at pH 7 and at 
4°C and 20°C for 24h (Table 2). In addition, they were stable after instant freezing (-20°C) and 
acidification for 24h up to three weeks. One study investigating the stability of MBDB in unfiltered 
wastewater at 2°C and at 20°C, both at pH 7, reported a medium stability with lower concentration 
after 12-24h (Baker and Kasprzyk-Hordern, 2011a).  265 
The transformation of MDPV and 12 metabolites – three of them previously reported as human 
metabolites – was investigated in wastewater at 22°C, and no significant decrease of MDPV (high in-
sewer and in-sample stability) was observed in a 10-day experiment (Mardal and Meyer, 2014). 
Further experiments demonstrated the glucuronidase activity in wastewater, since the signal of four 
glucuronide phase II metabolites decreased by more than 99% after one day (Mardal and Meyer, 270 
2014).  
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One study in unfiltered wastewater found that in-sample stability of mephedrone is high at 4°C and 
room temperature over 24h (Östman et al., 2014). Similarly, mephedrone was stable in urine at 4°C, 
room temperature and -20°C over at least 2 days (Johnson and Botch-Jones, 2013). Methylphenidate’s 
in-sample stability in wastewater ranged from medium (after 24h at 4°C) to low (at room temperature, 275 
Burgard et al., 2013; Östman et al., 2014). In Milli-Q water, methylphenidate was stable for 24h both 
at 4°C and at room temperature (Östman et al., 2014). Ritalinic acid had a high in-sample stability in 
wastewater for 72h at 20°C (Burgard et al., 2013).  
Few studies have investigated the influence of sewer biofilm or SPM on stability. The in-sewer 
stability study conducted by Thai et al. (2014) found a non-significant increase of METH (<5% after 280 
12h) in the presence of aerobic biofilm. Subedi et al. (2014) showed no sorption for METH, MDMA 
and MDEA and a medium loss (30 – 40%) due to sorption to SPM for MDA and AMP. In contrast, 
Baker et al. (2011b) found <10% of AMP sorbed to SPM (Baker and Kasprzyk-Hordern, 2011b).  
In general, the in-sample stability of AMP, METH, MDMA, MDA and MDEA in unfiltered and 
filtered wastewater samples at different temperatures have yielded similar results, demonstrating that 285 
these compounds had a high stability with the exception of AMP, for which a higher change in 
concentration was reported in some experiments (>20%) (Baker and Kasprzyk-Hordern, 2011a; 
Östman et al., 2014) (Table 2). 
2.4 Opiates  
Heroin use had been estimated by measuring its metabolite 6-monoacetyl morphine (6-MAM), 290 
however, 6-MAM itself has low in-sample stability and can transform quickly to morphine (MOR) in 
the wastewater matrix. A wastewater sample can lose up to 42% 6-MAM after 24h at 19°C (Baker and 
Kasprzyk-Hordern, 2011a). Similarly, in-sewer stability is low, since up to 90% of 6-MAM was lost at 
20°C after 12h in the study with sewer biofilms, performed by Thai et al. (2014). A reliable unbiased 
biomarker for heroin has not yet been found. 295 
Although the stability of morphine (MOR) is high in wastewater samples, the estimation of use of 
heroin from MOR concentrations is difficult, because it is used itself as a pharmaceutical and is a 
metabolite of other opiates (e.g., ethyl morphine, 6-MAM, codeine (COD)). The associated 
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glucuronides of MOR, morphine-3β-D-glucuronide and morphine-6β-D-glucuronide, can be measured 
in wastewater, but they have a low stability and quickly deconjugate to MOR (Table 2). 300 
Most of a COD dose is excreted with urine, either as unchanged COD or as a conjugate. COD is 
highly stable in wastewater samples (Table 2), and its consumption can, therefore, be estimated by 
measuring the load of COD in wastewater. Jelic et al. (2015) also reported high in-sewer stability. 
However, COD exhibited low stability in batch experiments with diluted activated sludge from 
wastewater treatment plants (Wick et al., 2011). 305 
Most wastewater studies to date measured both methadone (MTD) and its main metabolite EDDP, but 
the consumption of MTD was only estimated using the parent compound. Both MTD and EDDP seem 
to be stable in wastewater both under in-sample storage conditions (at 4°C, Östman et al., 2014) and 
simulated in-sewer conditions (at 19°C and pH 7, van Nuijs et al., 2012). However, a portion of MTD 
and EDDP can adsorb to SPM in wastewater. Baker and Kasprzyk-Hordern (2011a) observed a 310 
significant reduction of spiked MTD (23%) and EDDP (72%) in unfiltered wastewater after 72h at 
19°C, most likely due to sorption processes. Overall, the stability of MTD and EDDP is variable 
depending on the conditions and SPM/biofilm content. 
Buprenorphine has a variable stability in wastewater samples (Table 2). It is a relatively hydrophobic 
compound and eliminated primarily via feces as free drug with low concentrations occurring in urine. 315 
Oxycodone and fentanyl are therapeutic opiates that receive increasing attention as drugs of abuse. To 
date, all wastewater studies used the parent compounds as biomarkers, although each drug has specific 
metabolites (e.g., noroxycodone and norfentanyl, Baselt, 2008). Östman et al. (2014) found both 
compounds stable under storage condition, but Baker and Kasprzyk-Hordern (2011) observed 
significant degradation of fentanyl in unfiltered wastewater (62%) after 72h at 19°C and pH 7.4. This 320 
again may be attributed to adsorption to SPM, since only 6% of fentanyl was lost during the same 
period in filtered wastewater. Based on the reviewed studies, fentanyl had a medium in-sample 
stability, whereas oxycodone was highly stable. 
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2.5 Cannabinoids  
Cannabis’s primary active compound is Δ9-tetrahydrocannabinol (THC), which after consumption is 325 
metabolized to more than 20 metabolites, the two main ones being 11-nor-9-carboxy-THC (THC-
COOH) and 11-hydroxy-THC (THC-OH) (Karch and Jenkins, 2006). These metabolites are excreted 
as glucuronide conjugates, however in wastewater, they are hydrolyzed/deconjugated to the parent 
metabolite (Castiglioni et al., 2008). For this reason, THC-COOH is normally used to estimate 
cannabis consumption in WBE studies (Castiglioni et al., 2011b; Lai et al., 2011). However, there are 330 
analytical difficulties especially associated with the sample treatment and detection of THC-COOH 
due to its higher lipophilicity compared to other illicit drugs (Vazquez-Roig et al., 2013). This 
sometimes may hamper the inclusion of THC-COOH in analytical methods for routine multi-class 
determination of illicit drugs. 
In-sample stability tests with raw wastewater (pH 7-8) showed high stability over 72h with minimal 335 
impact of temperature (Table 2). However, after longer storage times at 4°C, degradation became 
more significant after seven days (González-Mariño et al., 2010). Frozen samples were stable up to 4 
months (Heuett et al., 2015b). Acidification of samples to pH 2 (with H3PO4) increased the 
transformation of THC-COOH and THC-OH in wastewater (Khan and Nicell, 2012; Senta et al., 
2014). At pH 2, THC-COOH was found to have enhanced adsorption (loss of 54%), compared to only 340 
10% loss at unadjusted pH 7.4 (Senta et al., 2013). This was also found in a similar study where only 
1.3% of THC-COOH was expected to have adsorbed to SPM at environmental pH conditions (pH ≈ 
7.5) (Khan and Nicell, 2012). 
2.6 Other substances 
The stability of lysergic acid diethylamide (LSD) in wastewater at pH 7.4 and acidified to pH 2 at 345 
room temperature and at 4°C after 24h was high (Table 2). The metabolite 2-oxo-3-hydroxy-LSD also 
exhibits high stability and only slightly decreased (10-20%) in wastewater pH 7.4 at room temperature 
after 24h, while acidification and/or lowering the temperature prevented this (Baker and Kasprzyk-
Hordern, 2011a; Chiaia et al., 2008).  
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The in-sample stability of ketamine (KET) and its metabolite norKET was studied for different 350 
conditions: temperature (4°C, room temperature), pH (2, 7.4), and time (12-72h) (Table 2). Both KET 
and norKET had a high stability in all analyzed conditions.  
3 Discussion 
The reviewed studies clearly show that concentrations of several substances decreased in unfiltered 
wastewater under different conditions. In order to explain discrepancies for a given biomarker among 355 
different studies with variable wastewater matrices, the effects of chemical, biological and physical 
processes need to be considered.  
Biological and chemical transformation processes 
In the absence of appropriate abiotic controls, it is difficult to differentiate between chemical and 
biological transformations. Several of the investigated biomarkers, e.g., COC and 6-MAM, have 360 
chemical structures (esters) that are prone to abiotic or biotic hydrolysis in wastewater. Abiotic control 
experiments were only carried out in three studies (Wick et al., 2011; Mardal and Meyer, 2014; Senta 
et al., 2014).  
Other important, chemically or biologically mediated, processes are conjugation and deconjugation. 
THC, morphine and MDPV are excreted in conjugated form (e.g., as glucuronides and sulfates) and 365 
tend to deconjugate during in-sewer transport (Boleda et al., 2007; D’Ascenzo et al., 2003; Evgenidou, 
2015, Mardal and Meyer, 2014).  
Studies of biological transformation (biotransformation) mechanisms related to biomarkers in sewers 
are scarce (Mardal and Meyer, 2014). Biotransformation can occur under aerobic and anaerobic 
conditions, whereby illicit drugs demonstrate affinity for bacterial enzymes and serve as co-metabolic 370 
(non-growth) substrates (Siegrist and Joss, 2012). In most of the reviewed stability studies, the redox 
conditions (aerobic/anaerobic) were not measured or monitored, even though the redox potential 
influences bacterial activity, and biotransformation is higher under aerobic than anaerobic conditions 
(Thai et al., 2014). The extent of biotransformation, therefore, depends on the type and amount of 
active biomass in the sewer, which may vary among different networks (Roth and Lemmer, 1994).  375 
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It is still not well understood which species of bacteria are responsible for biological transformation of 
organic micropollutants in wastewater treatment processes (Siegrist and Joss, 2012). Further, the 
microbial community in wastewater treatment plants deviates from sewer communities (Hvitved-
Jacobsen et al., 2013). The conditions in the activated sludge process in wastewater treatment are 
selected to favor growth of specific microorganisms, such as nitrifying and phosphorous-accumulating 380 
bacteria (Henze et al., 2002). Under the conditions prevailing in sewers, fast-growing heterotrophic 
bacteria outcompete the slower growing organisms, such as nitrifying bacteria (Hvitved-Jacobsen et 
al., 2013). Therefore, the use of activated sludge to mimic in-sewer transformation may not be 
representative for the active microbial community in sewers. Only one study that investigated the 
stability of illicit drug biomarkers included sewer wall biofilm (Thai et al., 2014), and the results 385 
implied that biofilm is an important parameter that needs to be taken into account.  
Another factor that may explain some of the variability in stability is the influence of other organic 
and inorganic constituents of SPM, such as feces and toilet paper (natural polymers, cellulose). These 
factors have not yet been investigated for their potential effect on transformations.  
Two of the key environmental variables influencing chemical and biological reactions are temperature 390 
and pH. Most studies reported or investigated the effect of these variables on the stability. Wastewater 
temperatures in sewers can vary from 10°C in winter up to 30°C in summer (Tchobanoglous and 
Burton, 1991). The reviewed transformation studies were conducted at constant temperature, either at 
low temperature (2-10°C) or at room temperature (19-23°C). Results show a temperature dependence 
of the transformation rates for COC, 6-MAM and morphine-3β-D-glucuronide (Senta et al., 2014). 395 
Similarly, (chemical and biological) hydrolysis rates of COC in wastewater were higher at 31°C 
compared to 23°C and 9°C. The transformation rate coefficients were larger than those reported in 
deionized water at similar pH and temperatures, confirming that biologically mediated hydrolysis can 
play an important role in wastewater (Bisceglia, 2007; Bisceglia and Lippa, 2014).  
The reviewed studies typically state one pH value, omitting whether pH was recorded at the beginning 400 
or end of the experiment or frequently monitored. A recent study found that biotransformation is pH-
dependent, where the neutral fraction of ionizable substances (e.g., amines) induced a higher microbial 
uptake (Gulde et al., 2014). During the transport of illicit drug biomarkers in sewers or over the course 
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of an experiment, transformations of macronutrients in the wastewater can change the pH (Sharma et 
al., 2013), which may change the bioavailability of biomarkers with pKas close to the wastewater pH. 405 
Spiking concentration levels 
All studies conducted multi-target analysis, which can make the interpretation of results difficult for 
some substances, if both parent compounds and metabolites were spiked together. To avoid this, one 
study spiked mass-labelled analogues to be able to differentiate between parent compound and 
metabolite transformations in separate batch experiments (Thai et al., 2014).  410 
Another limitation may arise if the selected excreted human biomarker is also a transformation product 
formed in the sewer (Heuett et al. 2015a). For example, the stability of an excreted metabolite may be 
low, but as a result of in-sewer transformation from the parent compound, a stability study may 
nonetheless exhibit constant concentration levels over the investigated period (as in the case of 
COC/BE). One approach to tackle this problem, then, is to use several biomarkers of one parent-415 
compound to more reliably back-calculate the consumption (Heuett et al., 2015a; Baker et al., 2014). 
This method is, however, only feasible when multiple metabolites are available and stable in the 
sewer. 
Spiking levels in the studies spanned from zero, i.e., relying on the concentrations already present in 
the wastewater, up to 100 µgL-1. It is necessary to distinguish between pathway investigation studies, 420 
where high spikes seem appropriate, and studies to monitor biomarker stability at environmentally 
relevant concentrations. Testing guidelines (e.g., Organization for Economic Cooperation and 
Development (OECD)) recommend high concentrations mostly to reduce analytical constraints.  
However, at high concentrations, microorganisms may need time to adapt before starting to transform 
illicit drugs (Mardal and Meyer, 2014). Thai et al. (2014) found no impact of high spiking levels on 425 
the transformation of COC, BE, MDMA and 6-MAM in their in-sewer stability study. Whether high 
levels of other illicit drugs may even inhibit biotransformation was not investigated and may require 
further comparative studies.  
Another, so far overlooked, aspect is the effect of spiking analytes dissolved in organic solvents. The 
typical solvent methanol is a potential substrate for microorganisms and may inhibit or enhance the 430 
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co-metabolic transformation of organic micropollutants (Plósz et al., 2010). A previous study found 
that the transformation of COC, BE and EME seems to be unaffected by the readily biodegradable 
substrate content present in pre-clarified sewage (Plósz et al., 2013).  
Physical processes 
The overall findings for sorption to SPM in the bulk liquid (i.e., excluding biofilm on sewer walls) 435 
were similar in most studies. A detailed description of the methods applied to conduct these control 
experiments can be found in the supporting information. Sorption has been shown to play a limited 
role for COC, BE, AMP, METH, MDMA and COD, whereas some sorption was observed for EDDP, 
fentanyl and MTD (Baker and Kasprzyk-Hordern, 2011a, 2011b; Bisceglia and Lippa, 2014; Langford 
et al., 2011; Senta et al., 2014). Even more so, THC-COOH tends to sorb to SPM with increased 440 
sorption at low pH values (Khan and Nicell, 2012; Senta et al., 2014, 2013).  No studies have 
specifically investigated the sorption of illicit drugs to the sewer biofilm. Substances that already tend 
to sorb to SPM in wastewater, e.g., THC-COOH, MTD and potentially LSD, may also sorb to sewer 
wall biofilms. Generally, since sorption is biomass-specific, extrapolating results from studies with 
SPM in wastewater to real systems with biofilm may not be adequate.  445 
4 Recommendations for future in-sewer experiments  
While it would be ideal to carry out in-sewer transformation studies in real sewers, there are several 
factors making full-scale experiments often (too) laborious to obtain accurate results, e.g., limited 
access to confined space, numerous confluents that would require monitoring and methods to 
experimentally account for unknown in- or exfiltration to close mass balances etc.,. Furthermore, due 450 
to varying environmental conditions that cannot be controlled during the experiments, several studies 
would be necessary. Based on the gaps identified in this review, we, therefore, propose the subsequent 
recommendations focusing on systematic laboratory and pilot-scale experiments to cover the wide 
range of realistic environmental conditions. This will facilitate interpretation and comparison of 
individual experiments, and allow to estimate the actual transformation potential in full-scale sewers.  455 
Biofilm 
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Generally, if in-sewer experiments are performed in the laboratory, all sewer compartments should be 
considered, including biofilms growing on the sewer walls. Since recent in-sewer studies showed that 
biofilm could enhance transformation, future studies should consider realistic types and amounts of 
sewer biofilm. The result is an increase of the total biomass in the system that can influence 460 
transformation rates.  
Reproducibility and monitoring 
A major challenge of using real, fresh wastewater is the reproducibility of results. Its composition is 
likely to differ from experiment to experiment; therefore, a meticulous approach to the assessment of 
its composition and monitoring of the environmental conditions is necessary. We propose the 465 
following minimum set of parameters to be included: total suspended solids (TSS), volatile suspended 
solids (VSS) and the main process variables, dissolved oxygen, temperature, pH, conductivity, 
dissolved inorganic sulfide/methane and soluble and total chemical oxygen demand.  
Spiking concentration levels 
The present illicit drug biomarker concentrations in grab samples or 24h composite samples may be 470 
too low to conduct meaningful experiments. Degradation pathways and relevant processes must be 
considered carefully when deciding to spike substances, including using a mix of analytes in one 
experiment or multiple experiments with individual analytes. Further, the aim of the study (pathway 
investigation or stability monitoring) influences the decision on concentration levels, and willingness 
for sample preparation (effort for SPE). For kinetic stability studies, spiking may be necessary to 475 
guarantee levels of substances to be sufficiently above the Limit of Quantification (LOQ). In some 
cases, the use of deuterated or 13C-labelled compounds might be needed, since illicit drugs may 
already be present in the wastewater matrix. For pathway investigation studies, the spike of usually 
only one compound at high concentrations may be necessary. Ideally, the spike should be done 
without organic solvent.  480 
Controls  
To facilitate interpretation and meaningful comparison of experiments carried out at different points in 
time, in different laboratories and under different conditions, appropriate controls must be included. 
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This can be done by analyzing substances with transformation behavior known from numerous 
studies, e.g., caffeine, nicotine (positive control) or carbamazepine (negative control). This may be 485 
helpful to compare different experiments and to confirm typical behavior in the setup.  
Abiotic controls without active biomass and enzymes present are necessary to account for losses due 
to volatilization and abiotic transformations, such as chemical hydrolysis. We recommend to filter (<1 
µm) and potentially autoclave the abiotic control reactor content (Gulde et al., 2014; Helbling et al., 
2010). 490 
For certain substances, sorption controls are necessary to interpret the transformation data correctly 
and distinguish between losses due to biotransformation or sorption.  
Experimental design and reporting of results 
In most stability studies, the stability is represented as percentage decrease or increase from the initial 
concentration, determined from a sample at time t0=0 and t=tend. In studies of micropollutant removal 495 
in wastewater treatment (pharmaceuticals, personal care products etc.), it is common to describe, if 
applicable, the exponential decrease in concentration over time with first-order kinetics 
(Schwarzenbach et al., 2003a). The resulting rate constants (kbio) are usually normalized to TSS or 
VSS, which facilitates comparison among different studies (i.e., different amount or activity of present 
biomass). We suggest performing in-sewer experiments over meaningful timeframes, which appears to 500 
be a relevant maximum hydraulic residence time in most sewer systems. To calculate rate constants, it 
is recommended to regularly collect samples, e.g., at the following points in time, related to the initial 
spike t(cbackground)= -5 min, t(c0)= 2 – 5 min after spike, 30 min, 1 h, 2 h, 4 h, 8 h, 16 h, 24 h. The results 
should then be presented in conjunction with a suitable transformation model. For most substances, 
this may be (pseudo) first-order kinetics (Bisceglia and Lippa, 2014; Plósz et al., 2013). 505 
Sampling  
In kinetic studies, terminating the transformation processes at exact time points is crucial. After 
collecting the sample, the activity of the microorganisms can be stopped by adding a microorganism 
deactivating substance (see Controls); however, this will not stop abiotic processes. Guidelines suggest 
flash freezing (using solid CO2 (dry ice)/acetone or liquid nitrogen bath), followed by lyophilization 510 
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and extraction, with alternative centrifugation (and filtration) and separate extraction of the liquid and 
solid phase (OECD, 2008). Sample preservation and storage recommendations are provided in Section 
5.  
5 Recommendations for preserving illicit drugs in wastewater samples 
In previous sections, stability of each specific compound has been discussed based on the available 515 
literature. However, most laboratories store and prepare samples for multi-class analysis. Therefore, in 
this section, recommendations on preserving illicit drugs are provided for multi-class methods. Key 
points associated with in-sample stability are: termination of transformation processes, filtration, 
preservation and long-term storage.   
In general, samples should be filtered prior to storage. Filtration is mainly carried out to stop potential 520 
biotransformation and prevent clogging when performing SPE. A variety of membrane and glass fiber 
filters, with different pore sizes as low as 0.1μm, are available and have been used (Baker and 
Kasprzyk-Hordern, 2011a; Östman et al., 2014). Smaller pore sizes are able to filter out suspended 
bacteria, but are more readily blocked, leading to an increase in preparation time (Chen et al., 2013). It 
is important to evaluate for possible losses of the analytes during the filtration process. The addition of 525 
mass-labelled internal standards prior to filtration and storage is recommended, in order to compensate 
for losses and transformation (Bijlsma et al., 2014; Castiglioni et al., 2013). Due to time constraints, 
wastewater samples are often frozen without previous filtration or the addition of labelled internal 
standards. In those cases, it is important to immediately add labelled internal standards after the 
sample has thawed. This can be justified by conducting freeze and thaw stability studies for the 530 
targeted analytes and accounting for the potential losses. 
The most important aspects relating to in-sample stability is storage. Addition of preservatives, pH 
adjustment and storage at different temperatures has been studied in order to determine their impact. 
However, in a multi-class method, a compromise must be made for the optimal storage conditions. For 
example, lowering the pH increases the stability of several illicit drugs, except for THC-COOH (Baker 535 
and Kasprzyk-Hordern, 2011c; Chen et al., 2013; González-Mariño et al., 2010; Senta et al., 2014). If 
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it is not possible to analyze the samples immediately, they can be stored upon arrival at -20°C without 
any adjustments. Alternatively, samples could be extracted on SPE cartridges and stored at -20°C. 
Using these approaches, analytes are stable for up to 3 to 6 weeks, respectively (Baker and Kasprzyk-
Hordern, 2011a; Chiaia et al., 2008; González-Mariño et al., 2010). 540 
The stability of illicit drugs continues to be an issue during the subsequent sample preparation. 
Although this relates more to the analytical methodology and, therefore, is out of the scope of this 
review, it is worth mentioning that issues, such as the use of silanized glassware and evaporation 
temperature for reconstitution of sample extracts, should be addressed (Baker and Kasprzyk-Hordern, 
2011a). 545 
For in-sample stability (in a closed container), the following variable parameters are recommended to 
be measured at least at the beginning and end of the experiment: pH, temperature, conductivity, TSS, 
VSS and soluble and total chemical oxygen demand. This will allow a more effective and reliable 
comparison of results among different experiments and conditions.  
6 Conclusions 550 
In wastewater-based epidemiology, the back-calculation currently used to estimate drug consumption 
at the population level does not account for potential in-sewer transformation of the targeted drug 
residues. This increases the uncertainty of estimates to an unknown degree.  
Since most experiments were conducted with different grab wastewater samples of unknown 
composition, the occurring transformation processes in the studies might have varied. In addition, each 555 
study reported a different level of detail about these wastewater components and the experimental 
conditions, complicating the interpretation and generalization of compound behavior. Several illicit 
drugs, such as MDMA, KET and MDPV, seem to have a high stability in different wastewater studies 
at neutral pH and temperatures up to 20°C. Also BE and AMP are most likely substances with high 
stability in those wastewater conditions; however, they may be formed as transformation products of 560 
other substances. Accordingly, the low stability of COC and 6-MAM seems to be well investigated. 
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More research is needed for the drugs with variable behavior or few performed studies, such as THC-
COOH, fentanyl, mephedrone and cathinones. 
 The few studies to-date show that in-sewer transformation is compound-specific, influenced by 
the prevailing environmental conditions in sewers (temperature, sewer type). There is a lack of 565 
studies systematically investigating the influence of the different environmental conditions (pH, 
suspended particulate matter, biofilm) on the transformation of illicit drugs.  
 In order to compare different studies and environmental conditions, a reproducible experimental 
approach with quality controls for in-sewer transformation studies is needed. Therefore, this 
review recommends a best-practice approach for future in-sewer stability studies. 570 
 Further, we summarize the best strategies to assure good in-sample stability of illicit drugs in the 
field of wastewater-based epidemiology. In multi-compound studies, most illicit drugs had a high 
stability at neutral pH and -20°C for at least three weeks. Alternatively, acidification of the 
sample preserved most drugs, except for THC and metabolites. 
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